HOME > BUSINESS
BUSINESS
- MSD’s Zerbaxa Launch Being Shelved after Foreign Particles Detected
May 27, 2019
- Big 3 Generic Makers Eke Out Growth in Japan, but Struggle in US; AG Momentum Continues: Jiho Tally
May 24, 2019
- Daiichi Sankyo Denies Report on Sales Deal on Its OTC Subsidiary
May 24, 2019
- Shionogi in Marketing Tie-Up with Molteni for Rizmoic
May 23, 2019
- Ono Offers Its Account of License Fee Row with Nobel Laureate
May 23, 2019
- Trelegy Hits Japan Shelves, Novartis Starts Accepting Orders for Kymriah
May 23, 2019
- AbbVie’s Japan Sales in 2018 Double on Maviret Boon
May 23, 2019
- Chugai to Set Up Research Base in Yokohama, Shutter 2 Labs
May 22, 2019
- Japan Pharma Market Shrinks 1.8% in FY2018: IQVIA
May 22, 2019
- 1st Oral Proceedings Held for Bayer Employee Damage Suit
May 21, 2019
- Oncolys Chief Wants Chugai Deal to Accelerate Telomelysin Development in Japan
May 21, 2019
- Daiichi Sankyo Returns Part of Govt Grant for H5N1 Influenza Vaccine Project after Missing Supply Target
May 21, 2019
- Taisho Completes Tender Offer for Vietnamese Drug Maker
May 21, 2019
- Reducing Production Cost of Stemirac Is Key Issue: Nipro Pres.
May 20, 2019
- Top 4 Wholesalers See Over 1% Operating Margins in FY2018, Thanks Partly to Distribution Improvement Guidelines
May 20, 2019
- Ribomic Confident in Efficacy Outcome of Upcoming PII of Wet-AMD Treatment with Just 40 Patients: Pres.
May 20, 2019
- Fuji Pharma to File Biosimilars for Japan Approval by 2021: President
May 20, 2019
- JCR to License Lysosome Storage Disease Treatment to Global Player by March 2020: Chairman
May 20, 2019
- Ohara Join Hands with Nigerian Pharma, Eying Future Population Growth in Africa
May 17, 2019
- Suzuken to Exclusively Distribute Kymriah in Japan
May 17, 2019
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
